Changes

Jump to navigation Jump to search
add spin
A proposal by the [[European Commission]] to relax a ban on [[Direct-to-consumer advertising]] in Europe of prescription drug treaments for AIDS, asthma and diabetes was rejected in October 2003 by the European Parliament.
 
Despite the result, the drug industry is hopeful that it will succeed in watering down the European Union ban on direct to consumer advertising (DTCA). Draft proposals from a working group, which includes members of the European Commission and the drug industry, have proposed a public private partnership to provide patient "information" on prescription medicines. [http://msnbc.msn.com/id/15046930/] It is a prospect that horrifies the medical watchdog group, Health Action International (HAI). In response to the latest EU push, HAI stated that "the pharmaceutical industry is in no position to provide the information people want, need and deserve; information that is unbiased, reliable and comparative." In 2004 a push to weaken the EU's DTCA ban was overwhelmingly rejected. HAI report that one of the European Union members of parliament defended the latest move on the grounds that "70% of the current MEPs were new to their positions." [http://www.haiweb.org/05102006/PressReleaseDTCARevisited.pdf] (pdf)
== SourceWatch Resources==
developer, editor
60,576

edits

Navigation menu